Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
A growing amount of evidence indicates that matrix metalloproteinases (MMPs) may play an important role in the pathogenesis of Alzheimer's disease (AD). Stromelysin-1 (MMP-3) plays a central role in activating latent-type MMPs, which are originally secreted as proenzymes. We examined MMP-3 immunoreactivity in the brains of patients who had suffered from Alzheimer's disease and in those of neurologically normal persons. The interstitium between myelinated axons and astrocytes in the white matter of all brain tissues, and senile plaques in the gray matter of the patients with AD were stained with a monoclonal antibody to MMP-3. Comparison of the number of senile plaques stained with the antibody against MMP-3 in the parietal cortex with that in the hippocampus showed that fewer plaques were stained in the hippocampus. The selective distribution of MMP-3 in the human brain suggests that MMP-3 might play an important role in the pathogenesis of AD, especially in the degradation of beta-amyloid protein.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Enhanced expression of MMP-2 and MMP-9 has been found in astrocytes surrounding amyloid plaques and in the neurons and glia of the hippocampus after intracerebroventricular Ab injection (25)(26)(27)(28).”
From Differential protective effects of connective tissue growth factor against Aβ neurotoxicity on neurons and glia (2017) · cites this paper as [27]
In the citing paper
“while increased levels of metaloproteinases MMP-1, MMP-3 and MMP-10 have also been reported in AD [223,224,225,226].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [226]
Citations
Cites
Alzheimer's Disease: A Central Role for Amyloid
Selkoe, D. J. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199409000-00003 · Cited by 751
Multiple domains of the large fibroblast proteoglycan, versican.
Zimmermann, D. R., & Ruoslahti, E. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08447.x · Cited by 652
A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursor
Miyazaki, K., Hasegawa, M., Funahashi, K., & Umeda, M. (1993) · Nature · doi:10.1038/362839a0 · Cited by 175
Su, J. H., Cummings, B. J., & Cotman, C. W. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90521-3 · Cited by 173
Deb, S., & Gottschall, P. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041641.x · Cited by 163
Snow, A. D., Mar, H., Nochlin, D., Kresse, H., & Wight, T. N. (1992) · Journal of Histochemistry & Cytochemistry · doi:10.1177/40.1.1370306 · Cited by 144
Backstrom, J. R., Miller, C. A., & Tökés, Z. A. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09352.x · Cited by 109
Roughley, P. J., White, R. J., & Poole, A. R. (1985) · Biochemical Journal · doi:10.1042/bj2310129 · Cited by 93
Yamada, T., Yoshiyama, Y., Sato, H., Seiki, M., Shinagawa, A., & Takahashi, M. (1995) · Acta Neuropathologica · doi:10.1007/bf00294800 · Cited by 85
Self-citationIsolation of a large aggregating proteoglycan from human brain.
Perides, G., Rahemtulla, F., Lane, W. S., Asher, R. A., & Bignami, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35919-2 · Cited by 73
Cited by
Items 101–134 of 134
Matrix metalloproteinase 3 haplotypes and dementia and Alzheimer's disease
Reitz, C., van Rooij, F. J. A., de Maat, M. P. M., den Heijer, T., Albert Hofman, D., Witteman, J. C. M., & Breteler, M. M. B. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.001 · Cited by 11
Mak, K. K., Nam, J. K., Chuang, Y., & Chen, L. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149954 · Cited by 10
Lana, D., Branca, J. J. V., Delfino, G., Giovannini, M. G., Casamenti, F., Nardiello, P., Bucciantini, M., Stefani, M., Zach, P., Zecchi‐Orlandini, S., et al. (2023) · Cells · doi:10.3390/cells12182258 · Cited by 12
“Moreover, astrocytes express A β degrading enzymes [32,33] and can clear small deposits of A β fibrils [29,34], although it is unclear whether these enzymes are released in peri-plaque gliosis.”
BackgroundIerusalimsky, V. N., Кулешова, Е. П., & Balaban, P. M. (2013) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2013-1961 · Cited by 8
“In AD patients, MMP-3 expression was also detected in hippocampal neurons, around amyloid plaques in the cortex, and in the interstitium of white matter (Yoshiyama et al. 2000).”
BackgroundWang, X., Li, B., Yu, X., Zhou, Y., Wang, K., & Gao, Y. (2023) · Molecular Medicine Reports · doi:10.3892/mmr.2023.13139 · Cited by 8
“…increased the mrna expression levels of MMP‑3 and MMP‑9, which are located around amyloid plaques and elevated in the brain of patients with ad (54,55). in the ra2 microglia cell line, excessive a β accumulation elevated the activity of MMP‑3 and subsequently activated PI3K/Akt signaling…”
Molecular and Therapeutic Targets for Amyloid-beta Plaques in Alzheimer's Disease: A Review Study
Thomas, J., & WILSON, S. K. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.3522.1 · Cited by 7
“…that MMP-2, MMP-3, and MMP-9 are important players in AD compared to the other MMPs (Brkic et al., 2015; Duits et al., 2015; Yin et al., 2006; Yoshiyama et al., 2000) MMP-2 is the major MMP that is directly linked to Aβ in the brain and the dysfunction of this enzyme exerts influence on the…”
BackgroundMicroglia: Roles of Microglia in Chronic Neurodegenerative Diseases
Wood, P. L. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-297-5_1 · Cited by 12
Zhiying, L. I., Li, J., Minqiang, L. I., Cai, A., Hong, L. I. U., Miao, G., Shan, T., & Jinghong, M. A. (2022) · Food Science and Technology · doi:10.1590/fst.48622 · Cited by 1
A review of plant-derived products regulating amyloid beta-degrading enzymes in Alzheimer’s disease
Honaramouz, B., Imenshahidi, M., & Hosseinzadeh, H. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158053 · Cited by 1
Xie, Y., Tian, J., Li, H., Peng, Y., Li, M., & Wu, Y. H. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1771310 · Cited by 1
Ikezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 1
Herber, D. L. (2004) · Digital Commons - University of South Florida (University of South Florida)
Cerebrospinal fluid biomarkers for differentiating between Alzheimer’s disease and Vascular dementia
Bjerke, M. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University)
On the contribution of MMP-2 and MMP-9 to the postnatal cerebellar corticogenesis
Ayoub, A. E. (2003) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.1939 · Cited by 1
PERINEURONAL NETS IN HIPPOCAMPAL AREA CA2: REGULATION BY ACTIVITY AND DISEASE
Carstens, K. E. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/khgn-dw13
Wang, P., Anderson, D. E., & Ye, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24208974
Wang, P., Anderson, D. E., & Ye, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24208992
Wang, P., Anderson, D. E., & Ye, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24208983
Wang, P., Anderson, D. E., & Ye, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24208980
Wang, P., Anderson, D. E., & Ye, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24208971
Wang, P., Anderson, D. E., & Ye, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24208977
Wang, P., Anderson, D. E., & Ye, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24208989
Wang, P., Anderson, D. E., & Ye, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24208986
Additional file 1 of Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease
Aksnes, M., Edwin, T. H., Saltvedt, I. T., Eldholm, R. S., Chaudhry, F. A., Halaas, N. B., Myrstad, M., Watne, L. O., & Knapskog, A.-B. (2023) · Figshare · doi:10.6084/m9.figshare.23118925
Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer
Laumet, G. O. (2010) · theses.fr (ABES) · doi:10.70675/94126786zf990z488ezb471z5f1d5686766c · Cited by 1
Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease
García‐González, L. (2020) · theses.fr (ABES) · doi:10.70675/a04672c0z1f4az472ezbcd5zbea446eac50c
Wang, Y., Zhu, S., Ma, Y., Chen, X., & Zhou, M. (2026) · Medicine · doi:10.1097/md.0000000000050560
The role of matrix metalloproteinases in Alzheimer's disease and small vessel disease
Nguyen, N., Huynh, S., Mroczko, B., & Glodzik, L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261494579
Metadata
- Authors
- Yoshiyama, Y., Asahina, M., & Hattori, T.
- Affiliations
- Chiba University (JP)
- Venue
- Acta Neuropathologica
- Published
- 2000-01-05
- Volume
- 99
- Issue
- 2
- Pages
- 91-95
- ISSN
- 0001-6322 (ISSN-L)
- OpenAlex
- W2033779398
- Cited by
- 128
- References
- 11
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 1 · 2023: 8 · 2022: 3 · 2021: 10 · 2020: 8 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 8 · 2013: 8 · 2012: 5
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- matrix metalloproteinase-3, stromelysin-1, Alzheimer's disease, amyloid plaques, white matter, hippocampus, parietal cortex, MMP activation
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Antibodies, Monoclonal, Astrocytes, Axons, Brain, Female, Hippocampus, Humans, Immunohistochemistry, Male, Middle Aged, Parietal Lobe, Reference Values, Matrix Metalloproteinase 3, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.